ÂÜÀòÂÒÂ×

Kamila M. Wolanin, PhD, MBA has an extensive background in research and commercial strategy within the pharmaceutical industry. With a focus on DNA damage response and targeted treatment in cancer, Kamila M. has held various roles at companies such as LEO Pharma, Pfizer, and the Danish Cancer Society. Wolanin is a Fellow of the European Commission and holds a Doctor of Philosophy in Cell/Cellular and Molecular Biology. Kamila M. also has degrees in Executive MBA, Certified Pharmaceutical Advisor, and molecular biology and human genetics.